Skip to main content
. 2021 Feb;13(2):1045–1054. doi: 10.21037/jtd-20-2808

Table 2. Time-to event outcomes—3-year probabilities and median times with 95% confidence limits.

Time-to event outcome Invasive mediastinal nodal staging 3-year probability (95% CI) Median in months (95% CI) P value
Nodal failure-free survival Yes 0.61 (0.49–0.72) 41 [35–62] 0.73
No 0.55 (0.43–0.66) 40 [29–64]
Nodal failure Yes 0.84 (0.72–0.91) 0.1
No 0.69 (0.56–0.79)
Any failure-free survival Yes 0.48 (0.36–0.60) 36 [24–41] 0.6
No 0.45 (0.33–0.57) 33 [19–53]
Any failure Yes 0.62 (0.48–0.73) 48 (36, ٭) 0.95
No 0.54 (0.41–0.66) 61 (31, ٭)
Distant failure-free survival Yes 0.63 (0.51–0.74) 41 [36, 50] 0.63
No 0.63 (0.51–0.73) 53 [39, 70]
Distant failure Yes 0.83 (0.71–0.74) 0.39
No 0.83 (0.71–0.73)
Overall survival Yes 0.65 (0.52–0.75) 43 [36, 62] 0.65
No 0.67 (0.54–0.76) 63 [39, 70]

٭, empty cells not estimable; Nodal Failure: represents freedom from nodal failure; Any Failure: represents freedom from any failure; Distant Failure: represents freedom from distant failure.